Newsletter Subject

Reproductive Rights Central to Wisconsin Ob/Gyn's Run for Congress

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Mon, Sep 16, 2024 10:44 PM

Email Preheader Text

Daily Headlines Monday, September 16, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIG

[MEDPAGE TODAY]( Daily Headlines Monday, September 16, 2024 Today's Top Stories for {NAME} [WASHINGTON WATCH]( [Reproductive Rights Central to Wisconsin Ob/Gyn's Run for Congress]( [PEDIATRICS]( [Medical Cannabinoids in Kids Linked to These Adverse Events]( [NEUROLOGY]( [Microplastics Found in Human Olfactory Bulbs]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Navigating CAR T-Cell Therapy for Non-Hodgkin Lymphoma in Community Practice]( [PSYCHIATRY]( [Severe Sleep Issues May Tell of Later Suicidal Behavior in Preteens]( [MEETING COVERAGE]( [Intimate Partner Violence Tied to Working Memory Decline Into Menopause]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [PUBLIC HEALTH & POLICY]( [Are Regulators the Root of the Problem of Serious Device Recalls?]( CME SPOTLIGHT [Navigating Transitions to Adult Care for Sickle Cell Disease: A Toolkit for Healthcare Providers and Their Patients]( [MEETING COVERAGE]( [Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer]( [PULMONOLOGY]( [High-Intensity Noninvasive Ventilation May Reduce Intubation for COPD Exacerbation]( [GASTROENTEROLOGY]( [GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [MEETING COVERAGE]( [Another Possible Treatment Option for Intermediate-Stage Liver Cancer]( [OB/GYN]( [Scientists Show How Pregnancy Changes the Brain in Innumerable Ways]( [PERSPECTIVES]( [Brain Health Risks: Digital Quality Measures and the Future of Neurological Care]( CME SPOTLIGHT [Latest Evidence for Treating Secondary AML]( [PERSPECTIVES]( [Immediate Test Result Access: The Good, the Bad, and the Complicated]( [PUBLIC HEALTH & POLICY]( [Florida Hospitals Ask Immigrants About Their Legal Status. Texas Will Try It Next.]( [ONCOLOGY/HEMATOLOGY]( [Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation]( CME SPOTLIGHT [Decoding Indolent Systemic Mastocytosis: A Deep Dive Into Pathophysiology, Recognition, and Evidence-Based Diagnosis]( [ENDOCRINOLOGY]( [What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists?]( [MEDICAL JOURNEYS]( [For Your Patients: How Is Alzheimer's Disease Diagnosed?]( [MEDICAL JOURNEYS]( [The Complex Pathogenesis and Genetics of Alzheimer's Disease]( CME SPOTLIGHT [Maximizing Multiple Myeloma Care: What Hematology/Oncology Teams Need to Know About Bispecific Antibodies]( # Weekly Survey [Would Trump Sign a National Abortion Ban?]( During the recent presidential debate, former president Donald Trump [declined to say whether he would veto a national abortion ban.]([VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-09-16&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.